WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 3 fonti

AstraZeneca pauses £200m Cambridge expansion amid NHS pricing row

Drug companies increasingly frustrated with the Government over surging NHS clawbacks

Raccontata da

telegraph.co.uk

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

telegraph.co.ukStai leggendo9 mesi fa

AstraZeneca pauses £200m Cambridge expansion amid NHS pricing row

Drug companies increasingly frustrated with the Government over surging NHS clawbacks

bbc.com9 mesi fa

AstraZeneca pauses £200m Cambridge investment

Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.

Leggi questa versione → originale

Timeline cronologica

mercoledì 10 settembre 2025·telegraph.co.uk
US drugmaker scraps plans for £1bn UK research centre
Merck criticises ‘successive UK governments’ as it cancels King’s Cross development
venerdì 12 settembre 2025·telegraph.co.uk
AstraZeneca pauses £200m Cambridge expansion amid NHS pricing row
Drug companies increasingly frustrated with the Government over surging NHS clawbacks

cnbc.com9 mesi fa

AstraZeneca pauses $270 million investment in Britain

AstraZeneca has paused a planned investment in the U.K., which had been set to create 1,000 jobs.

Leggi questa versione → originale

venerdì 12 settembre 2025·

bbc.com

AstraZeneca pauses £200m Cambridge investment

Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest there.

sabato 13 settembre 2025·

cnbc.com

AstraZeneca pauses $270 million investment in Britain

AstraZeneca has paused a planned investment in the U.K., which had been set to create 1,000 jobs.